Allspring Global Investments
ANIK icon

Allspring Global Investments’s Anika Therapeutics ANIK Stock Holding History

Allspring Global Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39,352
Closed -$591K – 1628
2025
Q1 		$591K Sell
39,352
-2,922
-7% -$48.6K ﹤0.01% 1399
2024
Q4 		$696K Sell
42,274
-25,528
-38% -$503K ﹤0.01% 1374
2024
Q3 		$1.67M Buy
67,802
+9,440
+16% +$245K ﹤0.01% 1207
2024
Q2 		$1.48M Sell
58,362
-6,908
-11% -$179K ﹤0.01% 1245
2024
Q1 		$1.66M Buy
65,270
+14,259
+28% +$345K ﹤0.01% 1244
2023
Q4 		$1.16M Sell
51,011
-4,201
-8% -$86.9K ﹤0.01% 1302
2023
Q3 		$1.03M Sell
55,212
-20,619
-27% -$428K ﹤0.01% 1355
2023
Q2 		$1.97M Buy
75,831
+26,268
+53% +$703K ﹤0.01% 1239
2023
Q1 		$1.42M Buy
49,563
+906
+2% +$27K ﹤0.01% 1342
2022
Q4 		$1.44M Sell
48,657
-26,080
-35% -$742K ﹤0.01% 1340
2022
Q3 		$1.78M Buy
74,737
+1,198
+2% +$27.6K ﹤0.01% 1268
2022
Q2 		$1.64M Buy
73,539
+55,679
+312% +$1.24M ﹤0.01% 1294
2022
Q1 		$448K Buy
17,860
+2,644
+17% +$80.6K ﹤0.01% 2274
2021
Q4 		$545K Buy
+15,216
New +$609K ﹤0.01% 2251

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Allspring Global Investments's ANIK Position: Q2 2025 in Review

Allspring Global Investments sold out of Anika Therapeutics (ANIK) in Q2 2025, closing a stake of 39,352 shares — an estimated $591K sold.

Allspring Global Investments first reported a position in ANIK in Q4 2021 and held it in 14 quarters. The position peaked at $1.97M in Q2 2023. 103 funds tracked by Wall St. Rank hold ANIK as of Q2 2025.

  • Allspring Global Investments reported no remaining Anika Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 39,352 Anika Therapeutics shares in Q2 2025, an estimated $591K.
  • Allspring Global Investments first reported a position in Anika Therapeutics in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's Anika Therapeutics position peaked at $1.97M in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.